List of Parion Sciences patents

Patents where

Current Assignee

Name

Parion Sciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7368447 Capped pyrazinoylguanidine sodium channel blockers	Patent 7368447 was granted and assigned to Parion Sciences on May, 2008 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7368447	May 6, 2008
‌ US Patent 7368451 Capped pyrazinoylguanidine sodium channel blockers	Patent 7368451 was granted and assigned to Parion Sciences on May, 2008 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7368451	May 6, 2008
‌ US Patent 7247636 Phenolic guanidine sodium channel blockers	Patent 7247636 was granted and assigned to Parion Sciences on July, 2007 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7247636	July 24, 2007
‌ US Patent 10106551 Monothiol mucolytic agents	Patent 10106551 was granted and assigned to Parion Sciences on October, 2018 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10106551	October 23, 2018
‌ US Patent 7399766 Soluble amide & ester pyrazinoylguanidine sodium channel blockers	Patent 7399766 was granted and assigned to Parion Sciences on July, 2008 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7399766	July 15, 2008
‌ US Patent 11578042 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide		Parion Sciences	Parion Sciences	United States Patent and Trademark Office	11578042	February 14, 2023
‌ US Patent 10752597 3,5-diamino-6-chloro-N—(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide		Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10752597	August 25, 2020
‌ US Patent 7247637 Capped pyrazinoylguanidine sodium channel blockers	Patent 7247637 was granted and assigned to Parion Sciences on July, 2007 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7247637	July 24, 2007
‌ US Patent 7189719 Sodium channel blockers	Patent 7189719 was granted and assigned to Parion Sciences on March, 2007 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7189719	March 13, 2007
‌ US Patent 7368450 Sodium channel blockers	Patent 7368450 was granted and assigned to Parion Sciences on May, 2008 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7368450	May 6, 2008
‌ US Patent 7192958 Sodium channel blockers	Patent 7192958 was granted and assigned to Parion Sciences on March, 2007 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7192958	March 20, 2007
‌ US Patent 10968233 Monothiol mucolytic agents	Patent 10968233 was granted and assigned to Parion Sciences on April, 2021 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10968233	April 6, 2021
‌ US Patent 7868010 Capped pyrazinoylguanidine sodium channel blockers	Patent 7868010 was granted and assigned to Parion Sciences on January, 2011 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7868010	January 11, 2011
‌ US Patent 9346753 Dithiol mucolytic agents	Patent 9346753 was granted and assigned to Parion Sciences on May, 2016 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	9346753	May 24, 2016
‌ US Patent 8980898 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases	Patent 8980898 was granted and assigned to Parion Sciences on March, 2015 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	8980898	March 17, 2015
‌ US Patent 10071970 Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity	Patent 10071970 was granted and assigned to Parion Sciences on September, 2018 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10071970	September 11, 2018
‌ US Patent 9408988 Inhaled hypertonic saline delivered by a heated nasal cannula	Patent 9408988 was granted and assigned to Parion Sciences on August, 2016 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	9408988	August 9, 2016
‌ US Patent 8211895 Capped pyrazinoylguanidine sodium channel blockers	Patent 8211895 was granted and assigned to Parion Sciences on July, 2012 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	8211895	July 3, 2012
‌ US Patent 10246425 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds	Patent 10246425 was granted and assigned to Parion Sciences on April, 2019 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10246425	April 2, 2019
‌ US Patent 9586911 Arylalkyl- and aryloxyalkyl-substituted epthelial sodium channel blocking compounds	Patent 9586911 was granted and assigned to Parion Sciences on March, 2017 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	9586911	March 7, 2017
‌ US Patent 9586910 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide	Patent 9586910 was granted and assigned to Parion Sciences on March, 2017 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	9586910	March 7, 2017
‌ US Patent 10167266 Sodium channel blockers	Patent 10167266 was granted and assigned to Parion Sciences on January, 2019 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10167266	January 1, 2019
‌ US Patent 9695134 3,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxamide compounds	Patent 9695134 was granted and assigned to Parion Sciences on July, 2017 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	9695134	July 4, 2017
‌ US Patent 7981898 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes	Patent 7981898 was granted and assigned to Parion Sciences on July, 2011 by the United States Patent and Trademark Office.		Parion Sciences	United States Patent and Trademark Office	7981898	July 19, 2011
‌ US Patent 10526292 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases	Patent 10526292 was granted and assigned to Parion Sciences on January, 2020 by the United States Patent and Trademark Office.	Parion Sciences	Parion Sciences	United States Patent and Trademark Office	10526292	January 7, 2020

Results per page:

82 results

0 selected

82 results

0 selected